@stephencca Think most shareholders who bought in high when this...

@stephencca Think most shareholders who bought in high when this company was a seen as as a solid growth company and why not Mayne bought Metrics in the States they developed this very successfully by buying a large parcel of adjoining land to allow for expansion doubling the the manufacturing Metrics manufacturing plant and also not only re developed by doubling the existing complex also updated updated the equipment / modernized the manufacturing complex to called state of the art by business market reviews not only this Mayne had secure contracts with a number of large US Pharma companies . Going off shore into the States by buying Metrics , establishing , developing , updating specialized manufacturing machinery need to cater for other US Pharma companies to use our services ( contracts) . This proved lucrative this growth proved successful both in capital appreciation and other Pharma companies ( large) under contract using our services . This is what early shareholders bought into and no it wasn't a full blown asset free speculative stock reliant of products we paid through the nose for to enrich the people who profited by way of commissions , etc , etc , etc getting ridiculously over valued products over the line costing ordinary shareholders some everything ( margin lending) to enrich these scumbags . For me hung in there in the hope somehow somehow we might luck out with a couple of products not over until the fat lady sings who knows . Trump if he gets in will take up where he left off 100% sure of that insofar collusion between named generic Pharma companies , believe this has a lot to do with speculative buyers reluctance to buy until hopefully we're in the clear . Impossible to predict means to us ( cost) if we're found to be complicit in price fixing .